Accurate determination of ataxin-2 polyglutamine expansion in patients with intermediate-range repeats

被引:13
|
作者
Hussey, J
Lockhart, PJ
Seltzer, W
Wszolek, ZK
Payami, H
Hanson, M
Gwinn-Hardy, K
Farrer, M
机构
[1] Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA
[2] Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL 32224 USA
[3] Athena Diagnost Inc, Worcester, MA 01605 USA
[4] New York State Dept Hlth, David Axelrod Inst, Albany, NY 12208 USA
[5] NINDS, Bethesda, MD 20892 USA
来源
GENETIC TESTING | 2002年 / 6卷 / 03期
关键词
D O I
10.1089/109065702761403397
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Spinocerebellar ataxia, type 2 (SCA2), results from an expansion of a stretch of polyglutamine repeats within the coding sequence of the ataxin-2 gene (ATX2), localized to chromosome 12q23-24. Recent studies have widened the clinical phenotype, notably for individuals with repeats of intermediate size, from 32 to 35 glutamine residues. This narrow range necessitates precise determination of repeat size. Diagnostic laboratories most often perform direct genotyping of ATX2 from polymerase chain-amplified patient DNA with subsequent sizing utilizing slab gel polyacrylamide gel electrophoresis (PAGE) or capillary electrophoresis. Using cloning and sequencing methods, we have constructed a ladder of ATX2 alleles of known size and sequence composition. This freely available size ladder will facilitate future quantification of expansions of the ATX2 locus.
引用
收藏
页码:217 / 220
页数:4
相关论文
共 50 条
  • [1] ALS RISK BUT NOT PHENOTYPE IS AFFECTED BY ATAXIN-2 INTERMEDIATE LENGTH POLYGLUTAMINE EXPANSION
    Soraru, G.
    Clementi, M.
    Forzan, M.
    Orsetti, V.
    D'Ascenzo, C.
    Querin, G.
    Palmieri, A.
    Ermani, M.
    Angelini, C.
    Pegoraro, E.
    NEUROLOGY, 2011, 76 (23) : 2030 - 2031
  • [2] Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients
    Lee, Teresa
    Li, Yun R.
    Ingre, Caroline
    Weber, Markus
    Grehl, Torsten
    Gredal, Ole
    de Carvalho, Mamede
    Meyer, Thomas
    Tysnes, Ole-Bjorn
    Auburger, Georg
    Gispert, Suzana
    Bonini, Nancy M.
    Andersen, Peter M.
    Gitler, Aaron D.
    HUMAN MOLECULAR GENETICS, 2011, 20 (09) : 1697 - 1700
  • [3] Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
    Andrew C. Elden
    Hyung-Jun Kim
    Michael P. Hart
    Alice S. Chen-Plotkin
    Brian S. Johnson
    Xiaodong Fang
    Maria Armakola
    Felix Geser
    Robert Greene
    Min Min Lu
    Arun Padmanabhan
    Dana Clay-Falcone
    Leo McCluskey
    Lauren Elman
    Denise Juhr
    Peter J. Gruber
    Udo Rüb
    Georg Auburger
    John Q. Trojanowski
    Virginia M.-Y. Lee
    Vivianna M. Van Deerlin
    Nancy M. Bonini
    Aaron D. Gitler
    Nature, 2010, 466 : 1069 - 1075
  • [4] Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
    Elden, Andrew C.
    Kim, Hyung-Jun
    Hart, Michael P.
    Chen-Plotkin, Alice S.
    Johnson, Brian S.
    Fang, Xiaodong
    Armakola, Maria
    Geser, Felix
    Greene, Robert
    Lu, Min Min
    Padmanabhan, Arun
    Clay-Falcone, Dana
    McCluskey, Leo
    Elman, Lauren
    Juhr, Denise
    Gruber, Peter J.
    Rueb, Udo
    Auburger, Georg
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    Van Deerlin, Vivianna M.
    Bonini, Nancy M.
    Gitler, Aaron D.
    NATURE, 2010, 466 (7310) : 1069 - U77
  • [5] Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis
    Chen, YongPing
    Huang, Rui
    Yang, Yuan
    Chen, Ke
    Song, Wei
    Pan, PingLei
    Li, JianPeng
    Shang, Hui-Fang
    NEUROBIOLOGY OF AGING, 2011, 32 (10) : 1925.e1 - 1925.e5
  • [6] The modulation of Amyotrophic Lateral Sclerosis risk by Ataxin-2 intermediate polyglutamine expansions is a specific effect
    Gispert, Suzana
    Kurz, Alexander
    Waibel, Stefan
    Bauer, Peter
    Liepelt, Inga
    Geisen, Christof
    Gitler, Aaron D.
    Becker, Tim
    Weber, Markus
    Berg, Daniela
    Andersen, Peter M.
    Krueger, Rejko
    Riess, Olaf
    Ludolph, Albert C.
    Auburger, Georg
    NEUROBIOLOGY OF DISEASE, 2012, 45 (01) : 356 - 361
  • [7] Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in ALS patients
    Spataro, R.
    Sproviero, W.
    Mazzei, R.
    Cavalcanti, F.
    Condino, F.
    Colletti, T.
    La Bella, V.
    Conforti, F. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 265 - 265
  • [8] Effects of the enlargement of polyglutamine segments on the structure and folding of ataxin-2 and ataxin-3 proteins
    Wen, Jingran
    Scoles, Daniel R.
    Facelli, Julio C.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2017, 35 (03): : 504 - 519
  • [9] ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes
    Renata Vieira de Sá
    Emma Sudria-Lopez
    Marta Cañizares Luna
    Oliver Harschnitz
    Dianne M. A. van den Heuvel
    Sandra Kling
    Danielle Vonk
    Henk-Jan Westeneng
    Henk Karst
    Lauri Bloemenkamp
    Suzy Varderidou-Minasian
    Domino K. Schlegel
    Mayte Mars
    Mark H. Broekhoven
    Nicky C. H. van Kronenburg
    Youri Adolfs
    Vamshidhar R. Vangoor
    Rianne de Jongh
    Tijana Ljubikj
    Lianne Peeters
    Sabine Seeler
    Enric Mocholi
    Onur Basak
    David Gordon
    Fabrizio Giuliani
    Tessa Verhoeff
    Giel Korsten
    Teresa Calafat Pla
    Morten T. Venø
    Jørgen Kjems
    Kevin Talbot
    Michael A. van Es
    Jan H. Veldink
    Leonard H. van den Berg
    Pavol Zelina
    R. Jeroen Pasterkamp
    Nature Communications, 15 (1)
  • [10] Conserved Pbp1/Ataxin-2 regulates retrotransposon activity and connects polyglutamine expansion-driven protein aggregation to lifespan-controlling rDNA repeats
    Lauren A. Ostrowski
    Amanda C. Hall
    Kirk J. Szafranski
    Roxanne Oshidari
    Karan J. Abraham
    Janet N. Y. Chan
    Christian Krustev
    Kevin Zhang
    Ashley Wang
    Yupeng Liu
    Ru Guo
    Karim Mekhail
    Communications Biology, 1